Table 1 Patients characteristics

From: FADD protein release mirrors the development and aggressiveness of human non-small cell lung cancer

Category

Subcategory

All patients with NSCLC ( n =50)

Surgery, n

HDH

28

 

IMM

22

Sex, n (%)

Male

32 (64%)

 

Female

18 (36%)

Age, year

Mean

63, 4

 

Range

44–82

Smoking history, n

Never smoker

21

 

Passive smoker

1

 

Smoker

28 (56%)

 

Pack/year, n

40 (mean) 5–>80 (range)

Preoperative chemotherapy, n (%)

Yes

8 (16%)

Histological type, n (%)

ADC

29 (58%)

 

SCC

13 (26%)

 

LCC

8 (16%)

Stage, n (%)

I

19 (38%)

 

IA

6

 

IB

13

 

II

11 (22%)

 

IIA

0

 

IIB

11

 

III

20 (40%)

 

IIIA

15

 

IIIB

5

 

IV

0

  1. Abbreviations: NSCLC=non-small cell lung cancer; ADC=adenocarcinoma; SCC=squamous cell carcinoma; LCC=large cell carcinoma; HDH=Hôtel-Dieu Hospital; IMM=Institut Mutualiste Montsouris; pTNM=pathologic TNM stage.
  2. Neoadjuvant chemotherapy was based on platinum salt regimens.